We previously found that exogenous GSH enhances mucosal GSH and promotes lipid hydroperoxide metabolism by rat small intestine (Aw, T. Y., and M. W. Williams. 1992. Am. J. PhysioL 263:G665-G672). In this study, we have developed an in vivo bile and lymph fistula rat model to test the hypothesis that biliary GSH is an important luminal source of GSH. Peroxidized fish oil was infused into the proximal intestine, and hydroperoxide accumulation in lumen, mucosa, and lymph was determined. Diversion of bile decreased mucosal GSH and increased hydroperoxide accumulation in all fractions. Supplementation with GSH, but not with GSSG, increased tissue GSH and attenuated hydroperoxide accumulation (50-60%), consistent with enhancement of hydroperoxide removal by exogenous GSH. Addition of native bile deficient in GSH, but not cysteine, cystine, or GSSG, decreased luminal and lymph hydroperoxide levels by 20-30%. Amino acid supplementation concurrently attenuated hydroperoxide recoveries in these fractions by 30-40% and increased mucosal GSH by 40%, indicating a role for biliary amino acids in hydroperoxide elimination. The effect of amino acids was abolished by buthionine sulfoximine, confirming their role in GSH biosynthesis. Collectively, the results demonstrate that bile is a rich source of reductant for maintaining mucosal GSH to promote intestinal metabolism of luminal peroxidized lipids. (J. Cmn. Invest. 1994Invest. .94:1218Invest. -1225.) Key words: omega-3 fatty acid hydroperoxides * en-
Introduction
Previous studies have documented that the uptake of exogenous GSH from the intestinal lumen provides an important means for enterocytes to enhance their cellular antioxidant pool ( 1-3). We recently established that the quantitative removal of 1 . Abbreviations used in this paper: BCNU, 1,3-bis(2-chloroethyl)1-nitrosourea; BF, bile and lymph fistula rat; BSO, L-buthionine-[S,R]-sulfoximine; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid.
luminal lipid hydroperoxides by rat small intestine is directly related to the mucosal GSH content (4) . The enhancement of mucosal GSH levels by exogenous GSH supplementation under conditions in which cellular GSH status is compromised can restore tissue GSH and promote hydroperoxide metabolism (5) . Taken together, these findings suggest that a constant supply of luminal GSH would be an important process in the maintenance of normal mucosal GSH. Moreover, the bioavailability of luminal GSH could ultimately determine the efficiency of mucosal hydroperoxide elimination and the susceptibility of the intestinal epithelium to oxidant injury.
Under physiological conditions, luminal GSH can arise from GSH present in the diet (6, 7) or from GSH excreted into bile (8) (9) (10) (11) (12) ). An important question that has not been addressed is the functional significance of the enterohepatic circulation in supply of GSH from bile to the small intestine and of the physiological relevance of biliary GSH in intestinal GSH homeostasis and detoxication of luminal oxidants. Despite lingering uncertainties regarding the mechanism and regulation of hepatic GSH transport into bile (10) (11) (12) (13) (14) , it is now known that the liver puts out as much as 50-60% of its total GSH export into bile (8, 9) . In the rat, minimal autoxidation of GSH occurs during bile transit (15) and, hence, the GSH concentration in rat bile is high (1-2 mM). Thus, this biliary GSH pool can potentially serve as a rich source of reductant for the metabolism of peroxidized lipids by the small intestine. The objective of the current study is, therefore, to test this hypothesis and to define a physiological role of biliary GSH in intestinal hydroperoxide elimination. The approach was to use the conscious bile fistula and lymph fistula rat to quantify luminal and mucosal recoveries and to measure directly lymph output of lipid hydroperoxides after steady state infusions of peroxidized fish-oil solutions. In previous studies, we have established that these parameters are accurate indexes of the efficiency of the metabolism of lipid hydroperoxides by the small intestine (4, 5) .
Methods

Animal surgery and postoperative care
Male Sprague-Dawley rats (250-300 g) were used. Surgery was performed in 24-h fasted rats. In control rats, only the lymph duct was cannulated, whereas in experimental animals (bile fistula [BF] ' rats), both the bile and lymph ducts were cannulated. Under isofluorane anesthesia, the major lymph duct above the superior mesenteric artery was cannulated according to Bollman et al. (16) . The hepatic bile duct was cannulated with a PE-lO tubing and secured with ties. A duodenal tubing was inserted via the stomach and secured with ties. In some animals, an additional tubing was secured to the wall of the peritoneal cavity for purposes of intraperitoneal administration of GSH-depleting agents. Rats were allowed to recover for 24 h postoperatively in restraining cages kept in a warm temperature-controlled chamber (30°C). During this period, the rats were infused with a 5% glucose-saline solution (0.3 M glucose, 145 mM NaCl, and 4 mM KCl) at a constant rate of 3 ml/ h to replace fluid and electrolyte loss in lymph and bile. The animals were comfortably confined but not tightly restrained under these conditions. All animal procedures have been approved by the Institutional Animal Review Board of the Louisiana State University (LSU) Medical Center.
Preparation of lipid hydroperoxide infusates
Lipid hydroperoxides were generated by air oxidation of MaxEPA fish oil for 5 d. Peroxidized fish-oil emulsions were prepared as previously described (4, 5) by sonicating 78 jimol egg phosphatidyl choline, 80 Amol MaxEPA fish oil, and 570 Amol taurocholate in 30 ml phosphatebuffered saline, pH 6.4. The amount of lipid hydroperoxides in the emulsions were typically 5% of the total lipid, and the quantity of lipids received by each rat was standardized to the actual amount of hydroperoxide content (1.5 tsmol). GSH, amino acids, and y-glutamyl glutamate, whenever present, were added to the lipid emulsions before the infusion at the specified concentrations as follows (mM): 1 GSH, 1 each glycine and glutamate, 0.5 cystine, and 10 y-glutamyl glutamate.
Experimental protocol Lipid infusions. Control and BF rats were infused with peroxidized fishoil emulsions without or with GSH (plus or minus y-glutamyl glutamate or acivicin) or amino acids at 3 ml/h for 8 h. Before lipid infusion, some BF animals were pretreated with buthionine sulfoximine (BSO) or with 1,3-bis(2-chloroethyl l-nitrosourea) (BCNU) as follows: 8 mmol/kg BSO in 0.9% saline was given as a single dose 2 h before lipid infusion, and 40 mg/kg BCNU in 5% ethanol and diluted with 0.9% saline was administered 14 h before lipid infusion. Acivicin (0.25 mM) was administered at 20 min before lipid infusion and was present throughout the infusion period. Lymph was collected into precooled conical centrifuge tubes at every 2-h interval for 0-2, 2-4, 4-6, and 6-8 h during the 8-h steady state intraduodenal infusion period. All samples were treated with 1% butylhydrotoluene to prevent oxidation. A 0.5-ml aliquot sample at each time interval was taken for measurements of lipid hydroperoxide. The remainder of the lymph was pooled and extracted with 3 vol of ether for analyses of the fatty acid hydroperoxides by HPLC (see below).
Collection of luminal and tissue samples. Collection was as described previously (4, 5) . Briefly, at the end of lymph collection, rats were killed by exsanguination under isofluorane anesthesia. The cecum and the small intestine were removed and placed on ice. The small intestine was divided into four equal segments and the luminal contents of each intestinal and cecal segment were thoroughly eluted with three washes of 3 ml of 10 mM sodium taurocholate. The intestinal segments were homogenized, and samples of tissue homogenates and luminal washings (intestinal and cecal) were taken for GSH and lipid hydroperoxide determinations.
Analytical methods
Total hydroperoxides were determined by the thiobarbituric acid assay as described previously (17) . Tissue GSH was determined by HPLC (18) . The hydroperoxy eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, the two major fatty acids of fish oil (19) , were analyzed by HPLC as described below. Separation of different lipid fractions in lymph was achieved by TLC (20) .
HPLC analyses offatty acid hydroperoxides. Oxidized triglycerides were digested with pancreatic lipase (21) and purified by TLC (20 concentration that is found in rat bile ( 15 ) , and measured luminal hydroperoxide recovery. The results show that GSH supplementation significantly attenuated peroxide accumulation in all segments of the intestine ( Fig. 1 ), consistent with a role for GSH in hydroperoxide elimination. To determine if the GSH effect was exerted intracellularly, we inhibited GSH transport by y-glutamyl glutamate (4, 5) . Under these conditions, luminal hydroperoxide accumulation was high, essentially the same as that in the absence of added GSH ( Fig. 1) , suggesting a requirement for GSH uptake for its effect. In comparison, inhibition of y-glutamyl transferase activities by > 95% with acivicin gave results that were similar to those in the presence of GSH ( Fig. 1 ). This indicates that the mechanism of action of acivicin on y-glutamyl transferase differs from that of y-glutamyl glutamate under the current conditions and is consistent with yglutamyl glutamate being an inhibitor of intestinal uptake of GSH. Taken together, these results show that biliary GSH is an important exogenous GSH source that can be directly taken up for use by the intestinal mucosa. Tissue recovery oflipid hydroperoxides. (4, 5) . In BF rats, the steady state output of hydroperoxide into lymph (4-8 h) was significantly higher than control, consistent with an enhanced hydroperoxide output into lymph consequent to a reduced intracellular metabolism of hydroperoxides in these animals. Interestingly, during the first 2 h of lipid infusion, the lymphatic transport of peroxidized lipids was low in BF ani- . Lymphatic transport of lipid hydroperoxides in BF rats: effect of GSH, y-glutamyl glutamate, and acivicin. Lipid hydroperoxides were determined in lymph collected from control and experimental rats at 2-h intervals over an 8-h steady intraduodenal infusion of peroxidized fish-oil emulsions. Each data point represents mean±SE for control (n = 6 rats; 0), bile fistula (BF; n = 6; .), BF plus 1 mM GSH (n = 7;
A), BF plus GSH and 10 mM y-glutamyl glutamate (n = 4; A), and BF plus GSH plus 0.25 mM acivicin (n = 4; o). Differences were observed between the following groups: BF vs control at 6-8 h (P < 0.001); BF plus GSH vs BF at 4 h (P < 0.005) and at 6-8 h (P < 0.001); BF plus GSH and y-glutamyl glutamate vs BF plus GSH at 4-8 h (P < 0.001); BF plus GSH and acivicin vs BF at 6-8 h (P < 0.001) and vs BF plus GSH and y-glutamyl glutamate at 6-8 h (P < 0.05).
mals, which probably reflects the poor absorption of the oxidized lipid (see Fig. 1 ). GSH supplementation caused a marked reduction in hydroperoxide transport into lymph that was reversed by y-glutamyl glutamate (Fig. 2) . In comparison, supplementation with GSH plus acivicin gave results that were similar to those with GSH alone (Fig. 2) . These results collectively show that mucosal uptake of luminal GSH supports tissue hydroperoxide metabolism and attenuates hydroperoxide output into lymph.
Distribution of fatty acid hydroperoxides in lymph lipid fractions. To assess the effects of GSH supplementation on the metabolic fate of EPA and DHA fatty acid hydroperoxides, we analyzed their distribution among the various lipid fractions in lymph. HPLC analyses showed that the oxidation of fish oil yielded equimolar amounts of hydroperoxy fatty acids of EPA and DHA as the major oxidation products (22) . As shown in Fig. 3 , EPA and DHA hydroperoxides were predominantly associated with triglycerides (85%) with a smaller fraction associated with free fatty acids (15%). In control rats, EPA and DHA hydroperoxide recovery in lymph lipid fractions was low but in BF rats recovery of the two hydroperoxides was significantly increased in the triglyceride fraction with little change in the free fatty acid fraction. This suggests that the oxidized fatty acids are mostly reesterified into triglycerides within the mucosa after their absorption from the lumen. The data in Fig.  3 further revealed that essentially equal amounts of EPA and DHA hydroperoxides were found in lymph triglycerides, indicating that reesterification of the two fatty acid hydroperoxides (Fig. 4) . Supplementing native bile with GSH significantly attenuated hydroperoxide recovery in the lumen and lymph by 60% and 45%, respectively (Fig. 4) , similar to the results obtained with GSH alone without bile (see Figs. 1 and 2). Tissue hydroperoxides were reduced by 30% with bile supplement compared with BF animals (Table II) , whereas the addition of GSH to bile further decreased mucosal hydroperoxide levels (Table II) (Fig. 6) . GSSG also exerted minimal effects on tissue hydroperoxides (Table II) . On the basis of these results, it appears that luminal GSSG is relatively ineffective in promoting hydroperoxide removal as compared with GSH or amino acids. This may be attributed to a lack of reduction of GSSG to GSH in the intestinal lumen under these conditions and/or to a poor cellular uptake and use of GSSG by the intestinal cells.
To compare the effectiveness of GSH and amino acids in the reduction of lipid hydroperoxides, BF animals were infused with different peroxide contents (from 1.0 to 5.0 ktmol) and equimolar concentrations of either GSH or the amino acid mixtures under control conditions or under conditions in which animals were pretreated with BCNU to inhibit mucosal GSSG reductase activity (55% inhibition; reference 4). In both groups, the rats exhibited marked distension of the small intestine and developed diarrhea at peroxide concentrations > 2 umol. In addition, between 4 and 8 h of the lymph collection period, lymph flow in control and experimental BF animals fell from 3 to 0.8 ml/h, indicating loss of absorptive and lymphatic functions. At the peroxide dose used in the current study ( 1.5 ymol), GSH and amino acids appear to exert similar effects on the accumulation of luminal and lymph lipid hydroperoxides (Figs. 5 and 6). These results are consistent with an inability of animals with severely compromised detoxication capacity to handle high peroxide doses efficiently; as a consequence, excessive hydroperoxide could accumulate in the intestinal lumen and lead to mucosal fluid loss and diarrhea.
Tissue levels of GSH To verify that the changes in luminal, mucosal, and lymph hydroperoxide contents related to bile diversion and of GSH and amino acid supplementation were associated with altered Figure 6 . Effect of GSSG on total luminal and lymph accumulation of lipid hydroperoxides in BF rats. BF rats were infused with peroxidized fish oil and GSH or GSSG, and the total luminal and lymph lipid hydroperoxide contents were determined as described in the text. Results are mean±SE for control (intact bile duct; n = 6), BF rats (BF; n = 7), BF plus GSH (n = 5), or BF plus GSSG (n = 6). *P < 0.001 in comparison with control; * *P < 0.001 in comparison with BF; 0P < 0.005 in comparison with BF plus GSH. (A) Luminal hydroperoxides; (B) lymph hydroperoxides.
LLmol/g; Table III ) and were not significantly different from the values in animals without peroxide exposure (1.51±0.09 /Lmol/g). These results show that acute exposure of the mucosa to a low dose of hydroperoxide caused little change in tissue GSH levels, suggesting that during low oxidant stress, steady state GSH status was well maintained.
Mucosal GSH concentrations were 50% lower in BF rats than in rats with intact bile duct (Table III) , supporting a role for biliary GSH in the maintenance of normal tissue GSH levels. Exogenous GSH supplementation in BF animals increased mucosal GSH concentrations to above control levels ( Table III), suggesting that biliary GSH can enhance the intracellular GSH pool. The increase in GSH levels associated with GSH supplementation was ameliorated by y-glutamyl glutamate but was not affected by acivicin (Table III) , consistent with GSH transport by intestinal cells. The addition of GSH-depleted native bile increased tissue GSH by 20%, whereas inclusion of GSH elevated cellular GSH to above control levels (Table III) . Supplementation with amino acids also elevated mucosal GSH levels, which was prevented by BSO (Table Ill) , confirming the role of amino acids in GSH synthesis. Exogenous GSSG was without effect on tissue GSH, which supports the above suggestion that GSSG was not a major source of cellular GSH under these conditions. Taken together, these results are consistent with biliary GSH and amino acids being important luminal sources of reductant, either via direct uptake or via biosynthesis, respectively, for the maintenance of the intracellular GSH concentrations.
Discussion
In the current study, the use of a bile and lymph fistula rat model provides a suitable in vivo approach to evaluate the physiological relevance of biliary GSH in intestinal handling of peroxidized lipids. This experimental approach was based on our earlier studies with the conscious lymph fistula rat in which we found a direct quantitative relationship between the intestinal elimination of luminal lipid hydroperoxides and the mucosal GSH status (4). We further found that exogenous GSH supplementation was effective in restoring tissue GSH and promoting hydroperoxide removal from the gut lumen under conditions of GSH deficiency (5) .
The current studies show that the absence of luminal bile caused an overall decrease in the metabolism of peroxidized lipids by the small intestine as reflected in significant accumula- (26) . However, given the length of time needed for differential cell isolation (3 h) and the time taken for lymph collection (8 h) for each animal, it was technically not feasible to combine the two methods in the same experiment. Thus, we cannot, at present, fully address the question of changes in hydroperoxide contents with regional changes in tissue GSH.
It is significant that GSH precursor amino acids are effective in enhancing intestinal mucosal GSH and promoting hydroperoxide elimination since biliary ductular epithelium (27, 28) and the intestinal brush border (29) is rich in y-glutamyl transferase, which functions to degrade GSH (30) , and luminal uptake of intact GSH occurs concurrently with hydrolysis of GSH, uptake of the constituent amino acids (2, 31), and intracellular GSH resynthesis. The current observation that luminal amino acids can be efficiently taken up by the intestine for intracellular GSH synthesis suggests that the recirculation of biliary GSH precursor amino acid could provide an important physiological mechanism to bolster intestinal antioxidant defenses, such as in human small intestine, given the low GSH content in human bile (Aw, T. Y., unpublished results).
A recognized limitation of the current in vivo approach is the lack of precise quantification of the respective contribution of GSH and amino acids to the maintenance of the steady state cellular GSH pool. Additionally, the source of reductant supply, i.e., luminal versus plasma, also cannot be readily assessed using this approach. Notwithstanding, recent studies provide some insights into the quantitative contribution of GSH synthesis and GSH uptake to maintaining enterocyte GSH concentration. We found that the rate of GSH synthesis in freshly isolated enterocytes from rat proximal intestine was low (0.031±0.002 nmol/ 106 cells per minute; reference 32) relative to other organs such as the liver (0.4-0.8 nmol/106 cells per minute; reference 33). By comparison, the rate of GSH uptake by enterocytes from the extracellular medium was 0.077±0.003 nmol/ 106 cells per minute (32) . Based on these studies in isolated enterocytes, the rate of GSH transport is at least twofold greater than the rate of GSH synthesis. If similar rates occur in vivo, the uptake of GSH from the intestinal lumen may quantitatively be more important than GSH synthesis in the optimal supply of GSH during enhanced hydroperoxide metabolism. Since phospholipids and bile salts are requisites for normal absorption of nonoxidized lipids (34), biliary amphiphilic compounds may also play a role in the absorption of oxidized fats. At present, little is known about the physicochemical properties of peroxidized lipids in the intestinal lumen and how oxidative modification of lipids could alter their physicochemical behavior in the luminal phases and formation of mixed micelles. Also, little is known of the cellular processing of fatty acid hydroperoxides after absorption. Our study shows that oxidized long-chain fatty acids are substrates for reesterification as evidenced by the significant association of hydroperoxy fatty acids with lymph triglycerides. Not surprisingly, however, the intestinal absorption and reesterification of oxidized long-chain unsaturated fatty acids are substantially poorer in comparison to those of nonoxidized unsaturated fatty acids (35) . Collectively, the current results underscore the significant impact that oxidation has on the absorptive, metabolic, and lymphatic transport phases of luminal lipids.
In summary, we have established an in vivo bile and lymph fistula rat model to evaluate the physiological significance of bile in intestinal metabolism of luminal peroxidized lipids. The results provided evidence for the importance of biliary GSH and its amino acids in maintaining mucosal GSH and enhancing cellular metabolism of lipid hydroperoxides. Since high lipid intake can promote oxidative injury to the intestinal epithelium by increased lipid peroxidation and subsequent propagation of oxygen radicals (36, 37) , the promotion of GSH-dependent hydroperoxide detoxication can effectively decrease the risk for development of various gut pathologies, such as inflammation and cancer.
